Page last updated: 2024-10-30

losartan and Aortic Stenosis

losartan has been researched along with Aortic Stenosis in 7 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Research Excerpts

ExcerptRelevanceReference
"Wistar rats were divided into the following 4 groups: 1) C--control (n=13); 2) AoS--aortic stenosis (n=11); 3) LIS--AoS treated with lisinopril, 20 mg/kg/day (n=11); and 4) LOS--AoS treated with losartan, 40 mg/kg/day (n=9)."3.73[Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis]. ( Aragon, FF; Cicogna, AC; Cordaro, FR; Gonçalves, G; Okoshi, K; Okoshi, MP; Padovani, CR; Ribeiro, HB; Zornoff, LA, 2005)
"Our data do not support a role for the AT1 receptor in the progression of atherosclerosis in this model, since blockade with losartan did not alter plaque distribution."3.73Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE-/- mice. ( Bergström, G; Gan, LM; Johansson, ME; Skøtt, O; Wickman, A, 2006)
" We investigated the changes of ceramide lipid components in hypertrophied immature rabbit hearts after chronic administration of the AT1 -receptor blocker, losartan."1.39Modulation of C16:0-ceramide in hypertrophied immature hearts by losartan. ( Itoi, T; Oka, T; Terada, N, 2013)
"Cardiac hypertrophy was induced by abdominal aortic stenosis (AAS) in Sprague-Dawley rats."1.33Role of myofibrillogenesis regulator-1 in myocardial hypertrophy. ( Li, T; Liu, X; Sun, S; Wang, Y; Xu, F, 2006)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's2 (28.57)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Flyer, JN1
Sleeper, LA1
Colan, SD1
Singh, MN1
Lacro, RV1
Lüscher, TF1
Itoi, T1
Oka, T1
Terada, N1
Hiyoshi, H1
Yayama, K1
Takano, M1
Okamoto, H1
Gonçalves, G1
Zornoff, LA1
Ribeiro, HB1
Okoshi, MP1
Cordaro, FR1
Okoshi, K1
Padovani, CR1
Aragon, FF1
Cicogna, AC1
Liu, X1
Li, T1
Sun, S1
Xu, F1
Wang, Y1
Johansson, ME1
Wickman, A1
Skøtt, O1
Gan, LM1
Bergström, G1

Other Studies

7 other studies available for losartan and Aortic Stenosis

ArticleYear
Effect of Losartan or Atenolol on Children and Young Adults With Bicuspid Aortic Valve and Dilated Aorta.
    The American journal of cardiology, 2021, 04-01, Volume: 144

    Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Angiotensin II Type 1 Receptor Blockers;

2021
Atherosclerosis, neoatherosclerosis, and vascular disease.
    European heart journal, 2015, Aug-21, Volume: 36, Issue:32

    Topics: Angiotensin II Type 1 Receptor Blockers; Aortic Diseases; Aortic Valve Stenosis; Cardiovascular Dise

2015
Modulation of C16:0-ceramide in hypertrophied immature hearts by losartan.
    Pediatrics international : official journal of the Japan Pediatric Society, 2013, Volume: 55, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newborn; Aortic Valve Stenosis; Cardiomeg

2013
Stimulation of cyclic GMP production via AT2 and B2 receptors in the pressure-overloaded aorta after banding.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:6

    Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; An

2004
[Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis].
    Arquivos brasileiros de cardiologia, 2005, Volume: 84, Issue:4

    Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic V

2005
Role of myofibrillogenesis regulator-1 in myocardial hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 290, Issue:1

    Topics: Amino Acid Sequence; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Animals, Newb

2006
Blood pressure is the major driving force for plaque formation in aortic-constricted ApoE-/- mice.
    Journal of hypertension, 2006, Volume: 24, Issue:10

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Aortic Valve Stenosis; Atherosclerosis; Blood Pres

2006